🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Qlaris Phase 2 clinical study investigating the safety, tolerability, and o...
Status
Completed
Location
Berkeley Eye Center
Start Date
2024-04-21
Trial ID
NCT06249152
Treatments Being Tested
The most common reason for contact lens discontinuation is contact lens dis...
Status
Completed
Location
Eye & Vision
Start Date
2016-12-16
Trial ID
NCT03686878
Treatments Being Tested
This randomized controlled trial evaluated whether a single drop of 0.5% ti...
Status
Completed
Location
CMH Institute of Medical Sciences
Start Date
2025-03-10
Trial ID
NCT07729189
Treatments Being Tested
This is a randomized trial comparing two elution doses of the Travoprost In...
Status
Completed
Location
John Berdahl, MD
Start Date
2016-03-29
Trial ID
NCT02754596
The purpose of this study was to compare the effects of Vigamox and Cravit ...
Status
Completed
Location
Multiple Locations
Start Date
2009-01
Trial ID
NCT00840580
Describe the efficacy of the use of topical besifloxacin in reducing the co...
Status
Completed
Location
Institute of Ophthalmology, Conde de Valenciana Foundation
Start Date
2017-01
Trial ID
NCT04542759
Treatments Being Tested
Single-blind, randomised, single centre, 2-way crossover study to collect p...
Status
Completed
Location
Glasgow Caledonian University
Start Date
2017-02-21
Trial ID
NCT03052140
Treatments Being Tested
The purpose of the study is to determine whether Moxidex ophthalmic solutio...
Status
Terminated
Location
Contact Alcon Call Center at 1-888-451-3937
Start Date
2007-12
Trial ID
NCT00579020
Compare the corneal penetration of levofloxacin 1.5% and moxifloxacin 0.5% ...
Status
Terminated
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT00764582
Treatments Being Tested
The purpose of this study was to determine the incremental intraocular pres...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-09-21
Trial ID
NCT03150160